Biotech Stock Longeveron Inc. (NASDAQ: LGVN) Makes Nasdaq Top Gainer List on News
Longeveron(US:LGVN) Investorideas.com·2026-03-10 16:00(Investorideas.com Newswire) a go-to platform for big investing ideas, including biotech stocks issues a news and trading alert for Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions. The stock makes the Nasdaq top percentage gainers list today, currently trading at $1.02, up $0.48, with a day’s high of $1.17 on a volume of over 141 million shares as of this report.Longeveron announced ...